Update in Kaposi sarcomaNoy, ArielaCurrent Opinion in Oncology: September 2003 - Volume 15 - Issue 5 - p 379-381 Cancer in AIDS Buy Abstract Author InformationAuthors Purpose of review Knowledge of the pathophysiology of Kaposi sarcoma continues to expand and influence our therapeutic approaches. This review summarizes developments within the last 18 to 24 months. Recent findings Pieces of the puzzle as they relate to viral factors—both human herpes virus 8 (HHV-8) and human immunodeficiency virus (HIV)—endothelial cells, host immune factors, and cytokines are described. Recent observations relating to highly active antiretroviral therapy (HAART) and agents under investigation that exploit the developments in pathophysiology are reviewed. Summary Advances in Kaposi sarcoma pathophysiology are leading to new therapeutic approaches. These will undoubtedly have an impact on other viral and malignant processes as well. Department of Lymphoma and Clinical Immunology, Division of Hematology, Memorial Sloan-Kettering Cancer Center, and Department of Medicine, Weill Medical College of Cornell University, New York, New York, USA. Correspondence to Ariela Noy, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA E-mail: email@example.com © 2003 Lippincott Williams & Wilkins, Inc.